Skip to Main Content

Login to your account

Show
Forgot password?
Don’t have an account?
Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Cancel
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
AJOG Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles Online First
    • Current Issue
    • List of Issues
    • Supplements
  • Collections
    • Back
    • AJOG Citation Classics
    • AJOG Eponyms
    • Coronavirus Guidance
    • COVID-19 Vaccines and Pregnancy
    • Editors' Choice
    • Focus on Intrauterine Devices
    • Giants in Obstetrics and Gynecology
    • MOC Part II
    • Preeclampsia
    • Press Releases
    • Reports of Major Impact
    • SMFM Supplements
  • For Authors
    • Back
    • About Open Access 
    • Information for Authors
    • Permission to Reuse Published Material
    • Researcher Academy 
    • Submit Your Manuscript 
  • Journal Info
    • Back
    • About Open Access 
    • About the Journal
    • Activate Online Access
    • Advisory Board
    • Affiliated Societies and Meeting Papers
    • Career Opportunities 
    • Contact Information
    • Editors and Editorial Board
    • In Our Third Century
    • Information for Advertisers 
    • Inappropriate Acts 
    • New Content Alerts
    • Pricing
  • Subscribe
  • SMFM Documents
    • Back
    • SMFM Documents by Year
    • SMFM Documents by Subject
  • Society Info
    • Back
    • Affiliates and Papers
    • SMFM Supplements
  • Multimedia
    • Back
    • AGOS Talks
    • Surgeon's Corner
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Reports of Major Impact
    • Said, Joanne MRemove Said, Joanne M filter
    Clear all

    Article Type

    • Research Article1

    Publication Date

    Author

    • Chamley, Larry W1
    • Groom, Katie M1
    • Hannan, Natalie J1
    • Kane, Stefan C1
    • Lee, Arier C1
    • Mackay, Laura K1
    • McCowan, Lesley M1
    • McLintock, Claire1
    • Stone, Peter R1
    • Tong, Stephen1
    • van Mens, Thijs E1
    • Walker, Susan P1

    Journal

    • American Journal of Obstetrics & Gynecology1

    Keyword

    • enoxaparin1
    • fetal growth restriction1
    • intrauterine growth restriction1
    • low-molecular-weight heparin1
    • preeclampsia1
    • randomized trial1
    • small for gestational age1

    Access Filter

    • Open Access

    Reports of Major Impact

    1 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Original Research Obstetrics

      Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial

      American Journal of Obstetrics & Gynecology
      Vol. 216Issue 3p296.e1–296.e14Published online: January 29, 2017
      • Katie M. Groom
      • Lesley M. McCowan
      • Laura K. Mackay
      • Arier C. Lee
      • Joanne M. Said
      • Stefan C. Kane
      • and others
      Cited in Scopus: 55
      Online ExtraEditor's ChoiceFast Track Articles
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Preeclampsia and small-for-gestational-age pregnancy are major causes of maternal and perinatal morbidity and mortality. Women with a previous pregnancy affected by these conditions are at an increased risk of recurrence in a future pregnancy. Past trials evaluating the effect of low-molecular-weight heparin for the prevention of recurrence of preeclampsia and small-for-gestational-age pregnancy have shown conflicting results with high levels of heterogeneity displayed when trials were compared.
        Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial
      Page 1 of 1
      • Home
      • Articles & Issues
      • Articles Online First
      • Current Issue
      • List of Issues
      • Supplements
      • Collections
      • AJOG Citation Classics
      • Coronavirus Guidance
      • COVID-19 Vaccines and Pregnancy
      • AJOG Eponyms
      • Editors' Choice
      • Focus on Intrauterine Devices
      • Giants in Obstetrics and Gynecology
      • MOC Part II
      • Preeclampsia
      • Press Releases
      • Reports of Major Impact
      • SMFM Supplements
      • For Authors
      • About Open Access
      • Information for Authors
      • Permission to Reuse Published Material
      • Researcher Academy
      • Submit Your Manuscript
      • Journal Info
      • About Open Access
      • About the Journal
      • Activate Online Access
      • Advisory Board
      • Affiliated Societies and Meeting Papers
      • Career Opportunities
      • Contact Information
      • Editors and Editorial Board
      • In Our Third Century
      • Information for Advertisers
      • Inappropriate Acts
      • New Content Alerts
      • Pricing
      • Subscribe
      • SMFM Documents
      • SMFM Documents by Year
      • SMFM Documents by Subject
      • Society Info
      • Affiliates and Papers
      • SMFM Supplements
      • Multimedia
      • AGOS Talks
      • Surgeon's Corner
      • Follow Us
      • Facebook
      • Twitter
      • Instagram
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

      • Privacy Policy  
      • Terms and Conditions  
      • Accessibility  
      • Help & Contact

      RELX